Galectin-1 inhibitors and their potential therapeutic applications: a patent review (Q38763827)

6 September 2017

title

Galectin-1 inhibitors and their potential therapeutic applications: a patent review (English)

1 reference

6 September 2017

Helen Blanchard

1

0 references

author name string

Khuchtumur Bum-Erdene

series ordinal

2

1 reference

6 September 2017

Mohammad Hussaini Bohari

series ordinal

3

1 reference

6 September 2017

Xing Yu

series ordinal

4

1 reference

6 September 2017

language of work or name

English

0 references

publication date

7 March 2016

1 reference

Expert Opinion on Therapeutic Patents

6 September 2017

published in

1 reference

6 September 2017

volume

26

1 reference

6 September 2017

issue

5

1 reference

6 September 2017

page(s)

537-554

1 reference

Introduction to galectins

6 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Multivalent protein-carbohydrate interactions. A new paradigm for supermolecular assembly and signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Binding and cross-linking properties of galectins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Oligosaccharide specificity of galectins: a search by frontal affinity chromatography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Galectin-1: a small protein with major functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Intracellular functions of galectins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Understanding the biochemical activities of galectin-1 and galectin-3 in the nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Galectin interactions with extracellular matrix and effects on cellular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Role of galectin-1 in the developing mouse olfactory system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Galectin-1-secreting neural stem cells elicit long-term neuroprotection against ischemic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Secretion of the galectin family of mammalian carbohydrate-binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Evidence for export of a muscle lectin from cytosol to extracellular matrix and for a novel secretory mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Galectin-1, a beta-galactoside-binding lectin in Chinese hamster ovary cells. I. Physical and chemical characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Galectins as pattern recognition receptors: structure, function, and evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Galectin-1 as a potent target for cancer therapy: role in the tumor microenvironment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

The sweet and bitter sides of galectins in melanoma progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

The role of galectins in colorectal cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Galectin-1 and immunotherapy for brain cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Hierarchical and selective roles of galectins in hepatocarcinogenesis, liver fibrosis and inflammation of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Galectin expression in cancer diagnosis and prognosis: A systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Galectin-1 and -9 in angiogenesis: a sweet couple.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Regulatory role of glycans in the control of hypoxia-driven angiogenesis and sensitivity to anti-angiogenic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Neural stem cells, adult neurogenesis, and galectin-1: from bench to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Galectin-1 as a potential cancer target

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Unraveling galectin-1 as a novel therapeutic target for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Glycobiology in malignant gliomas: expression and functions of galectins and possible therapeutic options

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Host-soluble galectin-1 promotes HIV-1 replication through a direct interaction with glycans of viral gp120 and host CD4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Galectin-1-specific inhibitors as a new class of compounds to treat HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Apoptosis of T cells mediated by galectin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Beta-galactoside-binding protein secreted by activated T cells inhibits antigen-induced proliferation of T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Recombinant galectin-1 and its genetic delivery suppress collagen-induced arthritis via T cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Targeted disruption of the galectin-3 gene results in attenuated peritoneal inflammatory responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Galectins and their ligands: amplifiers, silencers or tuners of the inflammatory response?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Galectins as inflammatory mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Galectins: novel anti-inflammatory drug targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Galectin-1 research in T cell immunity: past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Galectin-1 as a potential therapeutic target in autoimmune disorders and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Roles of galectins in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

A novel biological activity for galectin-1: inhibition of leukocyte-endothelial cell interactions in experimental inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Context-dependent multifunctionality of galectin-1: a challenge for defining the lectin as therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Growth-regulatory human galectin-1: crystallographic characterisation of the structural changes induced by single-site mutations and their impact on the thermodynamics of ligand binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Monovalent interactions of galectin-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Dimeric galectin-1 binds with high affinity to alpha2,3-sialylated and non-sialylated terminal N-acetyllactosamine units on surface-bound extended glycans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Characterization of monomeric forms of galectin-1 generated by site-directed mutagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Galectins: a family of animal lectins that decipher glycocodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Structural and functional studies of galectin-1: a novel axonal regeneration-promoting activity for oxidized galectin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Functional and structural bases of a cysteine-less mutant as a long-lasting substitute for galectin-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Structural basis of redox-dependent modulation of galectin-1 dynamics and function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Oxidized galectin-1 stimulates macrophages to promote axonal regeneration in peripheral nerves after axotomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Galectin-1 binds oncogenic H-Ras to mediate Ras membrane anchorage and cell transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Redox state influence on human galectin-1 function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Galectin-1(L11A) predicted from a computed galectin-1 farnesyl-binding pocket selectively inhibits Ras-GTP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Fragment-based development of triazole-substituted O-galactosyl aldoximes with fragment-induced affinity and selectivity for galectin-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Synthesis of a phenyl thio-beta-D-galactopyranoside library from 1,5-difluoro-2,4-dinitrobenzene: discovery of efficient and selective monosaccharide inhibitors of galectin-7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Aryl O- and S-galactosides and lactosides as specific inhibitors of human galectins-1 and -3: role of electrostatic potential at O-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Synthesis of stable and selective inhibitors of human galectins-1 and -3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

3-(1,2,3-Triazol-1-yl)-1-thio-galactosides as small, efficient, and hydrolytically stable inhibitors of galectin-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Arginine binding motifs: design and synthesis of galactose-derived arginine tweezers as galectin-3 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Double affinity amplification of galectin-ligand interactions through arginine-arene interactions: synthetic, thermodynamic, and computational studies with aromatic diamido thiodigalactosides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Studies of arginine-arene interactions through synthesis and evaluation of a series of galectin-binding aromatic lactose esters

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

A lactosylated steroid contributes in vivo therapeutic benefits in experimental models of mouse lymphoma and human glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Inhibition of prostate cancer bone metastasis by synthetic TF antigen mimic/galectin-3 inhibitor lactulose-L-leucine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Synthetic galectin-3 inhibitor increases metastatic cancer cell sensitivity to taxol-induced apoptosis in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Synthetic lactulose amines: novel class of anticancer agents that induce tumor-cell apoptosis and inhibit galectin-mediated homotypic cell aggregation and endothelial cell morphogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Galectin inhibitory disaccharides promote tumour immunity in a breast cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Differential roles of galectin-1 and galectin-3 in regulating leukocyte viability and cytokine secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Galectin-inhibitory thiodigalactoside ester derivatives have antimigratory effects in cultured lung and prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Synthesis and evaluation of new thiodigalactoside-based chemical probes to label galectin-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Mammalian galectins bind galactoseβ1-4fucose disaccharide, a unique structural component of protostomial N-type glycoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Taloside inhibitors of galectin-1 and galectin-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Synthetic multivalent ligands in the exploration of cell-surface interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Lactose-containing starburst dendrimers: influence of dendrimer generation and binding-site orientation of receptors (plant/animal lectins and immunoglobulins) on binding properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Wedgelike glycodendrimers as inhibitors of binding of mammalian galectins to glycoproteins, lactose maxiclusters, and cell surface glycoconjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Rigidified multivalent lactose molecules and their interactions with mammalian galectins: a route to selective inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Persubstituted cyclodextrin-based glycoclusters as inhibitors of protein-carbohydrate recognition using purified plant and mammalian lectins and wild-type and lectin-gene-transfected tumor cells as targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Calix[n]arene-based glycoclusters: bioactivity of thiourea-linked galactose/lactose moieties as inhibitors of binding of medically relevant lectins to a glycoprotein and cell-surface glycoconjugates and selectivity among human adhesion/growth-regula

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Synthesis of lactosylated glycoclusters and inhibition studies with plant and human lectins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Multimeric lactoside "click clusters" as tools to investigate the effect of linker length in specific interactions with peanut lectin, galectin-1, and -3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Inhibitory potential of chemical substitutions at bioinspired sites of β-D-galactopyranose on neoglycoprotein/cell surface binding of two classes of medically relevant lectins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Galectin-3 inhibitors: a patent review (2008-present).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Designed beta-sheet peptides that inhibit proliferation and induce apoptosis in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Advances and prospects of anginex as a promising anti-angiogenesis and anti-tumor agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

beta-Sheet is the bioactive conformation of the anti-angiogenic anginex peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

NMR solution structure of the angiostatic peptide anginex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Angiostatic peptides use plasma fibronectin to home to angiogenic vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Ovarian tumor growth regression using a combination of vascular targeting agents anginex or topomimetic 0118 and the chemotherapeutic irofulven

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Inhibiting tumor growth by targeting tumor vasculature with galectin-1 antagonist anginex conjugated to the cytotoxic acylfulvene, 6-hydroxylpropylacylfulvene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Scheduling of radiation with angiogenesis inhibitors anginex and Avastin improves therapeutic outcome via vessel normalization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Cloning an artificial gene encoding angiostatic anginex: From designed peptide to functional recombinant protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Anti-angiogenesis and anti-tumor activity of recombinant anginex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Design of a partial peptide mimetic of anginex with antiangiogenic and anticancer activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Structure-based optimization of angiostatic agent 6DBF7, an allosteric antagonist of galectin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Design of nonpeptidic topomimetics of antiangiogenic proteins with antitumor activities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Pharmacokinetics and antineoplastic activity of galectin-1-targeting OTX008 in combination with sunitinib.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Polycationic calixarene PTX013, a potent cytotoxic agent against tumors and drug resistant cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

The anti-angiogenic peptide anginex greatly enhances galectin-1 binding affinity for glycoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Antitumor agent calixarene 0118 targets human galectin-1 as an allosteric inhibitor of carbohydrate binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

The anti-angiogenic peptide anginex disrupts the cell membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Glycosylation-dependent lectin-receptor interactions preserve angiogenesis in anti-VEGF refractory tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Targeting galectin-1 overcomes breast cancer-associated immunosuppression and prevents metastatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Human thymic epithelial cells express an endogenous lectin, galectin-1, which binds to core 2 O-glycans on thymocytes and T lymphoblastoid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Recombinant human β-galactoside binding lectin suppresses clinical and histological signs of experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Galectin-1 suppresses experimental colitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Lung cancer-derived galectin-1 mediates dendritic cell anergy through inhibitor of DNA binding 3/IL-10 signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

High galectin-1 expression correlates with poor prognosis and is involved in epithelial ovarian cancer proliferation and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Galectin 1 expression is associated with tumor invasion and metastasis in stage IB to IIA cervical cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Enhanced apoptotic activity of a structurally optimized form of galectin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Structural features of galectin-9 and galectin-1 that determine distinct T cell death pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Galectin multimerization and lattice formation are regulated by linker region structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Development of a Nascent Galectin-1 Chimeric Molecule for Studying the Role of Leukocyte Galectin-1 Ligands and Immune Disease Modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Intra-articular lentivirus-mediated delivery of galectin-3 shRNA and galectin-1 gene ameliorates collagen-induced arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Pharmacologic transgene control systems for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Amelioration of graft versus host disease by galectin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Recent advances in characterization of nonviral vectors for delivery of nucleic acids: impact on their biological performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Engineering the nanoparticle-protein interface for cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Liposome-based Formulation for Intracellular Delivery of Functional Proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Effect of pegylation on pharmaceuticals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Polyethylene glycol-superoxide dismutase, a conjugate in search of exploitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Single-site mutational engineering and following monoPEGylation of the human lectin galectin-2: effects on ligand binding, functional aspects, and clearance from serum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Galectin-1 Augments Ras Activation and Diverts Ras Signals to Raf-1 at the Expense of Phosphoinositide 3-Kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

Decreased galectin-1 immunoreactivity of the skin in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2016.1163338

10.1517/13543776.2016.1163338

21 January 2018

Identifiers

DOI

1 reference

release_vu266rzsgzafxcp7bxgq246fpi

6 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/vu266rzsgzafxcp7bxgq246fpi

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference